Anencephaly

WikiDoc Resources for Anencephaly
Articles
Most recent articles on Anencephaly Most cited articles on Anencephaly Review articles on Anencephaly Articles on Anencephaly in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Anencephaly Images of Anencephaly Photos of Anencephaly Podcasts & MP3s on Anencephaly Videos on Anencephaly
Evidence Based Medicine
Cochrane Collaboration on Anencephaly Bandolier on Anencephaly TRIP on Anencephaly
Clinical Trials
Ongoing Trials on Anencephaly at Clinical Trials.gov Trial results on Anencephaly Clinical Trials on Anencephaly at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Anencephaly NICE Guidance on Anencephaly NHS PRODIGY Guidance FDA on Anencephaly CDC on Anencephaly
Books
Books on Anencephaly
News
Anencephaly in the news Be alerted to news on Anencephaly News trends on Anencephaly
Commentary
Blogs on Anencephaly
Definitions
Definitions of Anencephaly
Patient Resources / Community
Patient resources on Anencephaly Discussion groups on Anencephaly Patient Handouts on Anencephaly Directions to Hospitals Treating Anencephaly Risk calculators and risk factors for Anencephaly
Healthcare Provider Resources
Symptoms of Anencephaly Causes & Risk Factors for Anencephaly Diagnostic studies for Anencephaly Treatment of Anencephaly
Continuing Medical Education (CME)
CME Programs on Anencephaly
International
Anencephaly en Espanol Anencephaly en Francais
Business
Anencephaly in the Marketplace Patents on Anencephaly
Experimental / Informatics
List of terms related to Anencephaly

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayesha Javid, MBBS[2]

For patient information click here

Anencephaly
The side view of the head of an anencephalic fetus. Source: https://en.wikipedia.org/
ICD-10	Q00.0
ICD-9	740.0
OMIM	206500
DiseasesDB	705
MeSH	C10.500.680.196

Overview

Anencephaly is a cephalic disorder in which there is the partial or total absence of the brain. It is an open neural tube defect occurs when the rostral (head) end of the neural tube fails to close resulting in the absence of a major portion of the brain, skull and spinal cord. Children with this disorder are born without a forebrain, the largest part of the brain consisting mainly of the cerebral hemispheres which is responsible for higher cognitive functions and cerebellum which control balance and movement. However, hindbrain is developed. The remaining brain tissue is often exposed - not covered by bone or skin.

Historical Perspective

• Anencephaly was first recognized in the 16th century. In 1989, Aubrey Milunsky and his colleagues observed a reduction in the cases of neural tube defects in the mothers who took folic acid supplements during pregnancy.
• In 1992, Thresa was born with anencephaly. Her parents knew their daughter is going to die. So, they requested if her organs could be used for transplantation. This initiated a debate on anencephalic infant organ donation.

Classification

Type of Anencephaly	Clinical features
Meroanencephaly	Meroanencephaly is a rare form of anencephaly. Fetus born have clinical features including misshapen skull bones and a vascular tissue protuberance called cerebrovasculosa.
Holoanencephaly	It is the most common type of anencephaly. In this condition, the entire fetus brain fails to develop except for the brain stem. Usually, infant survives for only one day after birth.
Craniorachischisis	It is the most severe type of anencephaly. Along with the cranial defect, fetus also has a defect in the vertebral column exposing the underlying neural tissue. Area cerebrovasculosa and area medullovasculosa fill the areas with cranial and spinal defects.

Pathophysiology

• By the 3rd week of gestation, the embryo has 3 layers, from outer to inner these layers are ectoderm, mesoderm and endoderm. Notochord in the mesoderm sends signal molecule called Sonic Hedgehog protein to the overlying ectoderm forming it a neuroectoderm.

• The neural plate folds and closes to form a tube-like structure called neural tube and neural crest cells. The neural tube then goes on to form structures of the adult brain.

• A neural tube defect occurs if the the opening of the neural tube, called neuropore, fails to close in the 4th week of gestation. Neural tube has two neuropores, rostral and caudial. Anencephaly results from failure of the rostral neuropore to close anteriorly around day 25.

• The craniofacial abnormalities in anencephaly are caused by abnormal induction by the neural crest cells.

Clinical Features

• Infants born with anencephaly have the following clinical features:
  • Facial features: Cleft lip, cleft palate.
  • CNS: Absence of bony covering over the back of the head, spina bifida, blindness, deafness.
  • GIT: Absence or underdeveloped organs, gastroschisis, omphalocele.
  • Genito-urinary system: Hypospadias, penile hypoplasia, renal agenesis.
  • Skeletal system: Clubbed foot, clubbed hands.
  • Lungs: Diapharagmatic hernia.

Differentiating Anencephalopathy from other Disorders

At times, anencephaly could be misdiagnosed with other similar diagnosis such as;

• exencephaly
• microcephaly

Epidemiology and Demographics

Incidence

In the United States, approximately 1,000 to 2,000 babies are born with anencephaly each year. In 2001, the National Center for Health Statistics reported 9.4 cases among 100,000 live births. Anually, more than 300,000 babies are born with neural tube defects throughout the world.

Demographics

In United States, the highest prevalence has been seen among the Hispanic . Female babies, whites and children born to mothers who are at extreme of ages are more likely to be affected by the disorder. Worldwide, Ireland and British Islands has higher prevalence as compared to Asia and Africa which has a lower prevalence rate.

Recurrence rate

Like any other neural tube defect, the recurrence rate of anencephaly is 2-4 percent if one sibling is affected and 10 percent if two siblings are affected. This familial tendency is due to genetics, environmental factors, or both.

Risk Factors

Folate deficiency

• Studies show that most of the neural tube defects are caused by folic acid deficiency.
• This inadequate folate could be due to less oral intake, decreased intestinal absorption, or due to abnormal folate metabolism due to gene mutation. Some drugs antagonize the effect of folic acid resulting in folic acid deficiency and hence NTD. Most important ones are anti-epileptic drugs such as valproic acid and carbamazepine. Also, methotrexate, which is an antineoplastic drug also used for the treatment of ectopic pregnancy, has been linked with increased risk of NTD.

Genetics

Neural tube defects do not follow direct patterns of heredity, though there is some indirect evidence of inheritance. Recent animal models indicate a possible association with deficiencies of the transcription factor TEAD2.

The motivation behind studying genetic patterns is the following:

1. NTDs are consistently prevalent among monozygotic twins as compared to dizygotic twins.
2. There is a high recurrence rate within families. Statistics show the recurrence risk of 1/20 if one previous pregnancy is affected and 1/10 if two pregnancies are affected in a family.
3. There is higher female preponderence as compared to the males.

Syndromes

• Anencephaly is associated with:
  • Trisomy 13 or Trisomy 18
  • Meckel-Gruber syndrome
  • Roberts syndrome
  • Jarcho-Levin syndrome
  • HARD (hydrocephalus, agyria and retinal dysplasia)
  • OEIS complex (omphalocele, exstrophy of the cloaca, imperforate anus and spinal defects)
  • Limb-body wall complex (LBWC)

Fever/hyperthermia

• If a pregnant mother’s core body temperature elevates from baseline it could lead to congenital anomalies such neural tube defects, including anencephaly.
• The risk is more profound if this happens during the first trimester as this is the time during which organogenesis takes place. The National Birth Defects Prevention Study (NBDPS) infers that the risk of birth defects due to maternal infection-related fever can be reduced by the usage of acetaminophen.

Amniotic bands

• If a pregnant mother develops amniotic bands, it could affect the normal development and growth of the central nervous system. It could result in neural tube defects including anencephaly.

Pregestational diabetes

• If a woman has uncontrolled diabetes mellitus before conception, it could result in neural tube defects including anencephaly.
• Therefore, close monitoring of periconceptional glycemic level is essential to prevent neural tube defects and other congenital anomalies.

Maternal Obesity

• Obesity doubles the risk of neural tube defects. Also, it provides a limitation to fetal imaging.
• Folic acid supplementation does not decrease this risk of NTD, therefore it is mandatory to control weight before conceiving.

Toxins

• Anencephaly and other physical and mental deformities have also been blamed on high exposure to such toxins as lead, chromium, mercury, and nickel.

Diagnosis

Diagnostic Criteria

• The diagnosis of Anencephaly is made either during a prenatal scan or after the birth.

• In prenatal ultrasound, features like absent calvarium and characteristic frog-like appearance or Micky mouse appearance of the fetus are diagnostic.
• After the birth, clinical features like lack of bony covering over the back of the head and less number of bones around the front and sides of the head are diagnostic.

Symptoms

• [Disease name] is usually asymptomatic.
• Symptoms of [disease name] may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Physical examination may be remarkable for:

• Flattened head
• Absence of the cranial vault
• Positive grasp reflex in both the hands and feet
• Moro reflex could be present or absent depending on the severity of the defect.
• A heart murmur could be present due to associated congenital heart disease.
• cleft lip and/or cleft palate could be present.
• Clubbed foot could be present.
• Gastroschisis, omphalocele, hypospadias not always but could be present in some anencehalic infants.

Laboratory Findings

• There are no specific laboratory findings associated with [disease name].

• A [positive/negative] [test name] is diagnostic of [disease name].
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with [disease name].

• [Imaging study 1] is the imaging modality of choice for [disease name].
• On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• [Disease name] may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Prenatal screening

• American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics and Genomics (ACMG) advocates universal screening of all the pregnant women for the NTD.
• This results in early diagnosis which helps the couple to plan either pregnancy termination or otherwise prepare them for the birth. The maternal serum alpha-fetoprotein (AFP screening) and detailed fetal ultrasound can be useful for screening for neural tube defects such as spina bifida or anencephaly.

Ultrasound

Ultrasound provides a definitive diagnosis of anencephaly before birth. It can often be diagnosed through a transvaginal ultrasound performed at 12th week postmenstrual.

The ultrasound findings include:

• Absent calvarium.
• No parenchymal tissue above the orbits.
• Reduced crown rump length (CRL)
• A characteristic frog-like appearance or Micky mouse appearance of the fetus due to absent brain and cranial bone and, protruding orbits.
• A large amount of amniotic fluid called polyhydromnios is also seen.

Anencephaly - frog like appearance on prenatal USG. Source: https://radiopaedia.org

Alpha-Fetoprotein

• Alpha-fetoprotein (AFP) levels can be measured in maternal serum (MSAFP), amniotic fluid, and fetal plasma.
• Normally, the level rises in early pregnancy, peaks between 10 and 13th week, and then the level declines becoming extremely low near the term.
• For the purpose of prenatal screening, alpha-fetoprotein levels are checked and are found to elevated. This test is non-specific for NTD, as AFP can also be elevated due to other maternal and fetal factors. Therefore, results should always be combined with ultrasound findings and the levels of Acetylcholinesterase (AChE).

Acetylcholinesterase

AChE is an enzyme contained in blood cells, muscle, and nerve tissue. Its levels can be checked from the amniotic fluid via amniocentesis. An elevation of both AFP and AChE values is highly suggestive and accurate for fetal NTD.

Triple screen

Triple screen is a prenatal screening test which includes 3 biomarkers; AFP, hCG and estradiol. It helps to detect certain congenital anomalies, including neural tube defect. The following table shows the triple screening of neural tube defect and how it is differentiated from other anomalies.

Anomaly	AFP	hCG	Estradiol
NTD	Increased	Normal	Normal
Trisomy 21	Decreased	Increased	Decreased
Trisomy 18	Decreased	Decreased	Decreased

Natural History, Complications, Prognosis

• Prognosis of children born with anencephaly is extremely poor as there is no cure or standard treatment available so far. Most anencephalic babies do not survive birth, accounting for 55% of non-aborted cases. If the infant is not stillborn, then he or she will usually die within a few hours or days after birth from cardiorespiratory arrest.

• Anencephalic infants are not aggressively resuscitated as there is very little chance of the infant to achieve a full level of consciousness. Instead, clinicians prefer to provide them with adequate hydration, nutrition and comfort. Artificial ventilation, surgery (to fix any co-existing congenital defects), and medications are not considered an option as they have no role in any improvement. Due to this poor prognosis, couple are discussed about the option of the terminating the pregnancy soon after the prenatal diagnosis is established.

Diagnosis

Clinical features

• Infants born with anencephaly have the following clinical features:
  • Facial features: Cleft lip, cleft palate.
  • CNS: Absence of bony covering over the back of the head, spina bifida, blindness, deafness.
  • GIT: Absence or underdeveloped organs, gastroschisis, omphalocele.
  • Genito-urinary system: Hypospadias, penile hypoplasia, renal agenesis.
  • Skeletal system: Clubbed foot, clubbed hands.
  • Lungs: Diapharagmatic hernia.

Physical Examination

Neurologic

• Reflex actions such as breathing and responses to sound or touch may occur. Although some individuals with anencephaly may be born with a rudimentary brainstem, which controls autonomic and regulatory function, the lack of a functioning cerebrum is usually thought of as ruling out the possibility of ever gaining consciousness, even though it has been disputed specifically.

Cardio-vascular system

• In anencephaly, the cardiovascular system examination is usually normal. However, a murmur could be heard due to associated congenital heart disease.

Respiratory system

• In anencephaly, the respiratory system examination is usually normal. However, decreased breath sounds could be heard on auscultation if associated diaphragmatic hernia is present.

Gastrointestinal system

• In anencephaly, the gastrointestinal system examination is usually normal.

Management

So far, prevention is the best management of anencephaly.

Medical Therapy

• There is no known medical therapy available for anencephaly.

Surgery

• At this point in time, there are no surgical options available."Anencephaly: Causes, Symptoms, Diagnosis and Treatment for Newborns | St. Louis Childrens Hospital".

Prevention

• Recent studies have shown that the addition of folic acid to the diet of women of child-bearing age may significantly reduce, although not eliminate, the incidence of neural tube defects. Therefore, it is recommended that all women of child-bearing age consume 0.4 mg of folic acid daily, especially those attempting to conceive or who may possibly conceive, as this can reduce the risk to 0.03%.
• It is not advisable to wait until pregnancy has begun, since by the time a woman knows she is pregnant, the critical time for the formation of a neural tube defect has usually already passed. A physician may prescribe even higher dosages of folic acid (4 mg/day) for women who have had a previous pregnancy with a neural tube defect.

Pregnancy management

• Anencephaly has a poor pregnancy outcome. Majority of the fetuses are either stillborn or die soon after birth, however, few infants do manage to live up to 28 days.
• Therefore, mothers are counselled regarding the termination soon after the prenatal diagnosis. Vaginal delivery is the preferred mode unless there are any maternal indications.

References

Template:WikiDoc Sources